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Orthopoxviruses encode three serpin homologs—SPI-1, SPI-2 and SPI-3—of which SPI-2 has been well characterized as
an inhibitor of ICE-like proteases. A rabbitpox virus SPI-1 deletion mutant exhibited a host range restriction in human lung
A549 and pig kidney 15 cell lines that was attributed to apoptosis. Here we report that replication of a vaccinia virus SPI-1
deletion mutant (DSPI-1) was restricted in primary human keratinocytes as well as A549 cells. Although chromatin
condensation was detected in some A549 cells, other morphological or biochemical signs of apoptosis including DNA
fragmentation, cleavage of poly(ADP-ribose)polymerase or nuclear mitotic apparatus protein, or caspase 3 activation were
not found. Moreover, DSPI-1 protected A549 cells from apoptosis induced by tumor necrosis factor, whereas the corre-
sponding DSPI-2 mutant did not. Further studies indicated undiminished amounts of vaccinia virus early mRNA and replicated
DNA in the absence of the SPI-1 product. However, there were reduced amounts of viral intermediate and late mRNAs, viral
late proteins, cleaved core proteins, and virus particles. These data suggested that apoptosis is not the determining factor
in the host range restriction of DSPI-1 and that the SPI-1 gene product is needed to allow efficient expression of intermediate
and late genes in A549 cells.
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The best characterized poxviruses, of which vaccinia
irus is the prototype, belong to the orthopoxvirus genus
Moss, 1996). Although the host ranges of orthopoxvi-
uses are relatively narrow in nature, they are quite broad
n cultured cells and laboratory animals. Some muta-
ions, however, restrict the replication of orthopoxviruses
n specific cell types. In each case, the restriction occurs
t a stage after the penetration of virus particles into the
ytoplasm, pointing to important intracellular virus–host
nteractions. Deletion of the E3L gene, which encodes a
ouble-stranded RNA binding protein, impairs replication
f vaccinia virus in human HeLa, monkey Vero, and
urine L929 cells but not in rabbit kidney 13 cells or
hick embryo fibroblasts (Chang et al., 1992, 1995; Beat-
ie et al., 1996). Defective orthopoxvirus replication in
hinese hamster ovary (CHO) cells, caused by deletion
f the cowpox CHO hr gene, and in rabbit kidney 13 or
uman cells, caused by mutation of the vaccinia virus
1L gene, are correlated with defects in viral gene ex-
ression (Gillard et al., 1985; Spehner et al., 1988; Ram-
ey-Ewing and Moss, 1995, Ramsey-Ewing and Moss,
996). Modified vaccinia virus Ankara has multiple gene
1 Present address: University of Pennsylvania, Infectious Diseases
ection, 536 Johnson Pavilion, Philadelphia, PA 19104-6073.
2 To whom reprint requests should be addressed at 4 Center Drive,
SC 0445, National Institutes of Health, Bethesda, MD 20892-0445.Cax: (301) 480-1447. E-mail: bmoss@nih.gov.
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298efects (Meyer et al., 1991; Antoine et al., 1998; Wyatt et
l., 1998) that prevent replication at the level of virus
orphogenesis (Sutter and Moss, 1992) in many cell
ines except BHK-21 and in primary chick embryo fibro-
lasts (Carroll and Moss, 1997; Drexler et al., 1998).
poptosis has been associated with some orthopoxvirus
ost range mutations. Although apoptosis was delayed
n CHO cells infected with vaccinia virus containing an
ntact cowpox CHO hr gene, cell death is unlikely to play
significant role in host restriction of vaccinia virus
acking this gene (Ink et al., 1995; Ramsey-Ewing and
oss, 1998). Recently the viral serine protease inhibitor
serpin)-1 (SPI-1) gene was found to be necessary for
eplication of rabbitpox virus in human lung A549 and pig
idney 15 cell lines, and subsequent studies suggested
hat its role in these cells was to prevent apoptosis (Ali et
l., 1994; Brooks et al., 1995).
SPI-1 is one of three related orthopoxvirus genes with
equence motifs that place them in the serpin superfam-
ly. Serpins also are present in myxoma virus (Macen et
l., 1993; Petit et al., 1996; Messud-Petit et al., 1998; Nash
t al., 1998) and a murine gamma herpesvirus (Bowden
t al., 1997; Simas et al., 1998). Typically, serpins irrevers-
bly bind via their reactive center loop to serine pro-
eases and inhibit the activity of the latter (Whisstock et
l., 1998). Serpins have multiple roles and some are
nvolved in the regulation of immune and inflammatory
esponses and cell death (Bird, 1998). The best-charac-
erized orthopoxvirus serpin is SPI-2, also known as
rmA, which efficiently inhibits aspartic acid-specific
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299VACCINIA VIRUS SERPIN-1 MUTANTysteine proteases (caspases) and less efficiently inhib-
ts the aspartic acid-specific serine protease granzyme B
nd prevents IL1-b formation and cytokine-induced
poptosis (Ray et al., 1992; Quan et al., 1995; Tewari and
ixit, 1995; Ray and Pickup, 1996; Dobbelstein and
henk, 1996; Kettle et al., 1997). The SPI-1 gene encodes
protein that is 44% identical to SPI-2 but with a different
eactive center (Kotwal and Moss, 1989; Smith et al.,
989). Both proteins are expressed early in infection and
eside intracellularly (Kettle et al., 1995). SPI-1 can act
ynergistically with SPI-2 to block granule-mediated cell
illing pathways (Macen et al., 1996). The SPI-3 gene is
istantly related to SPI-1 and SPI-2 (Boursnell et al.,
988). Deletion of SPI-3 causes syncytium formation at
eutral pH, but the fusion-inhibitory role of the protein
oes not depend on serpin motifs (Law and Smith, 1992;
urner and Moyer, 1992, 1995; Zhou et al., 1992).
For the present study, we constructed a vaccinia virus
utant with nearly all of the SPI-1 gene deleted. This
utant was unable to replicate efficiently in either pri-
ary human keratinocytes or human A549 cells. Al-
hough some morphological signs of apoptosis were
bserved, there were no biochemical correlates of
poptosis, and the replication defect was associated
ith diminished levels of viral intermediate and late mR-
As, reduced viral late protein synthesis, and an inter-
uption of virion morphogenesis.
RESULTS
ost range restriction of a vaccinia virus SPI-1
eletion mutant
Homologous recombination was used to replace a
85-bp segment of the SPI-1 open reading frame of
accinia virus strain WR with a guanine phosphoribosyl
ransferase (gpt) expression cassette. Plaques that
ormed on BS-C-1 cells in the presence of mycophenolic
cid (Falkner and Moss, 1988) were purified repeatedly
nd virus stocks were prepared. The expected genomic
lterations were confirmed by Southern blotting (data not
hown), and the recombinant vaccinia virus was named
SPI-1. Another recombinant vaccinia virus named
SPI-2, with a 300-bp deletion in the SPI-2 gene, was
onstructed and used for comparative purposes.
The ability of the mutant viruses to propagate in sev-
ral different cell lines was determined by staining with
accinia virus antiserum. On BS-C-1 monolayers, both
SPI-1 and DSPI-2 formed large immunostaining
laques that were indistinguishable from those of wild-
ype vaccinia virus WR (Fig. 1). WR and DSPI-2 also
ormed large plaques on A549 cells, although the
laques increased in size more slowly than on BS-C-1
ells (Fig. 1). In contrast, only small clusters of immuno-
taining A549 cells were detected with DSPI-1. A specific
efect in DSPI-1 propagation also was found in primary
uman keratinocytes (Fig. 1). Similar results were ob- dained with independently derived keratinocytes from
ifferent individuals, indicating that this host range de-
ect was a consistent phenomenon. However, when the
eratinocytes were allowed to differentiate in medium
ontaining calcium and serum, the cells rapidly became
ermissive for DSPI-1. In addition, a continuous human
eratinocyte cell line (HaCaT) was permissive for DSPI-1
data not shown). Because of the tendency of primary
uman keratinocytes to convert to a permissive state,
urther detailed studies were carried out with A549 cells.
eplication of DSPI-1 is inhibited in A549 cells
A small plaque phenotype could result from a defect in
accinia virus replication or spread. Virus yields first
ere determined in BS-C-1 and A549 cells infected with
R or DSPI-1 at 0.01 plaque forming units (PFU) per cell.
t this multiplicity, replication and spread of WR and
SPI-1in BS-C-1 cells were virtually identical because
imilar peak infectivity titers were reached between 48
nd 72 h after infection (Figs. 2A and 2C). WR replicated
ore slowly in A549 cells than in BS-C-1 cells but
eached a similar titer by 96 h (Fig. 2A). In contrast, the
iter of DSPI-1 at 96 h was .4 logs lower in A549 cells
han in BS-C-1 cells (Fig. 2C).
One-step growth curves were constructed by infecting
S-C-1 and A549 cells with 10 PFU/cell of WR or DSPI-1.
n BS-C-1 cells, similar maximal titers of WR and DSPI-1
ere reached between 24 and 36 h after infection (Figs.
B and 2D). A similar titer also was obtained in A549
ells infected with WR (Fig. 2B). However, the titer of
SPI-1 was nearly 2 logs lower in A549 cells than in
S-C-1 cells (Fig. 2D). We concluded from these infectiv-
ty studies that the DSPI-1 has a specific replication
efect in A549 cells.
ransmission electron microscopy of permissive
nd nonpermissive cells infected with DSPI-1
Electron microscopic images of thin sections of BS-C-1
ells infected with DSPI-1 (Figs. 3A and 3C) or WR (Figs.
B and 3D) were indistinguishable, with abundant imma-
ure and mature forms of virus particles in each case.
eplication also appeared normal in A549 cells infected
ith WR (Figs. 3F and 3H), whereas mature virus parti-
les were rare in A549 cells infected with DSPI-1, and
here was a reduction in particles at all stages of mor-
hogenesis (Figs. 3E and 3G). In addition, at 24 h after
nfection with DSPI-1, ;7.5% of the A549 cells had con-
ensed chromatin and an invaginated nuclear mem-
rane suggestive of apoptosis (Fig. 3E). These nuclear
hanges were less prominent at 2, 6, and 12 h after
nfection of A549 cells with DSPI-1. Other classical mor-
hological features of apoptosis, such as nuclear frag-
entation, cytoplasmic vacuolization, and membrane
lebbing, or formation of apoptotic bodies were not evi-
ent. Similar though less pronounced nuclear changes
300 SHISLER, ISAACS, AND MOSS
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301VACCINIA VIRUS SERPIN-1 MUTANTFIG. 4. Biochemical correlates of apoptosis. (A) 10,000 A549 cells per chamber of an eight-well chamber slide were untreated (UN); treated with
0 mg/ml of CHX, 50 mg/ml of CHX, and 100 ng/ml of TNF; and infected with 10 PFU/cell of WR, DSPI-1, or DSPI-2. After 12 h, the cells were fixed and
tained to reveal nicked DNA. Slides were viewed under an inverted light microscope and photographed. (B) Analysis of protein cleavage products
y Western blot analysis. A549 cells were treated or infected as in (A). After 24 h, the cells were lysed and a portion of each lysate was analyzed by
estern blotting with antibody to NuMA (top), PARP (middle), or caspase-3 (bottom) followed by a horse radish peroxidase conjugated secondary
ntibody. Antibodies were detected by chemiluminescence. (C) After 12 h, mock-infected or infected A549 cells were incubated with indicated
oncentrations of TNF and percentage specific cytolysis was determined by measuring the release of lactate dehydrogenase.FIG. 1. Immunostained plaques formed by vaccinia virus WR, DSPI-1, and DSPI-2 in BS-C-1, A549, and primary human keratinocytes (PHK). After
8 h, infected cells were fixed, stained with an anti-vaccinia virus polyclonal antibody followed by a horse radish peroxidase-conjugated second
ntibody and then photographed.
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302 SHISLER, ISAACS, AND MOSSere present in 2% of the A549 cells at 24 h after
nfection with WR (Fig. 3F) but were not noted in unin-
ected A549 cells (not shown) or in BS-C-1 cells infected
ith WR or DSPI-1 (Figs. 3A and 3B). Brooks and cowork-
rs (Brooks et al., 1995) had reported that a high per-
entage of A549 cells infected with a rabbitpox virus
PI-1 mutant exhibited morphological signs of apoptosis
s well as chromatin degradation determined by TUNEL
ssay.
iochemical correlates of apoptosis
Because microscopy only provides a snapshot of ap-
ptotic events, we looked for biochemical correlates of
poptosis. DNA fragmentation was not detected by gel
lectrophoresis of A549 cells prelabeled with
125I]deoxyuridine and then infected with DSPI-1 (data not
hown), although this technique was previously used to
emonstrate DNA degradation in vaccinia-virus-infected
HO cells (Ramsey-Ewing and Moss, 1998). The more
FIG. 2. Replication of vaccinia virus WR and DSPI-1 in BSC-1 and A5
f WR or 0.01 (C) or 10 (D) PFU/cell of DSPI-1. The cells were harvested
laque assay on BS-C-1 cells.ensitive TUNEL assay showed dark, punctate staining cndicative of nicked DNA in some A549 cells infected
ith DSPI-1; however, the number of such stained cells
as similar in A549 cells infected with WR and DSPI-2 or
imply treated with cycloheximide (CHX) and much less
han in cells treated with CHX and tumor necrosis factor
TNF; Fig. 4A). Thus there was no correlation between
ost restriction and detection of DNA cleavage in A549
ells infected with wild-type or mutant vaccinia viruses.
The cleavage of poly(ADP-ribose)polymerase (PARP)
nd nuclear mitotic apparatus protein (NuMA) commonly
ccurs in apopotic cells (Casciola-Rosen et al., 1996;
eaver et al., 1996). Thus when A549 cells were treated
ith CHX or with CHX and TNF, the 116-kDa PARP
resent in control cells was diminished and the 89-kDa
roduct appeared (Fig. 4B). In contrast, only uncleaved
ARP was detected in A549 cells infected with WR,
SPI-1, or DSPI-2. Similarly, the 240-kDa NuMA protein
resent in control A549 cells was cleaved into smaller
pecies when treated with CHX and TNF (Fig. 4B). Less
s. BSC-1 and A549 cells were infected with 0.01 (A) or 10 (B) PFU/cell
indicated times and the virus titers in the lysates were determined by49 cell
at theleavage occurred when the A549 cells were treated
s
m
303VACCINIA VIRUS SERPIN-1 MUTANTFIG. 3. Electron micrographs of cells infected with WR or DSPI-1. BS-C-1 and A549 cells, infected for 24 h with WR or DSPI-1 were fixed, embedded,
ectioned, and examined by transmission electron microscopy. The magnification in each panel is indicated by a bar in the lower right corner. M,
ature intracellular virion; I, immature virion; DI, dense immature virion.
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304 SHISLER, ISAACS, AND MOSSith CHX alone and still less when infected with WR,
SPI-1, or DSPI-2 (Fig. 4B).
We also looked for earlier signs of apoptosis. PARP is
leaved by caspase-3, which is formed from a 32-kDa
recursor by cleavage at multiple aspartic acid sites
Keane et al., 1997). In normal A549 cells, only pro-
aspase-3 was detected, whereas in cells induced to
ndergo apoptosis by incubation with TNF and CHX,
ro-caspase-3 was reduced and caspase-3 was de-
ected (Fig. 4B). Some caspase-3 was detected in cells
reated with CHX alone but only pro-caspase-3 was de-
ected in cells infected with WR, DSPI-1, or DSPI-2 (Fig.
B).
As DSPI-1 did not induce apoptosis in the majority of
nfected A549 cells, we determined whether DSPI-1
ould protect A549 cells from death induced by TNF.
ver a wide concentration range, TNF only slightly en-
anced cytolysis of A549 cells infected with WR or
SPI-1 (Fig. 4C). By contrast, A549 cells infected with
SPI-2 were very sensitive to TNF-mediated cytolysis
Fig. 4C). Thus the absence of SPI-2 not SPI-1 rendered
549 cells sensitive to TNF-induced apoptosis, and this
id not correlate with host range restriction.
educed viral protein synthesis in A549 cells infected
ith DSPI-1
Although A549 cells infected with DSPI-1 exhibited
ome morphological signs of apoptosis, no biochemical
orrelates were found. We therefore sought to determine
hether the low yield of virus particles resulted from
iminished viral protein synthesis. BS-C-1 and A549 cells
ere labeled with [35S]methionine at various times after
nfection with WR, DSPI-1, or DSPI-2. After each labeling
eriod, lysates were prepared and analyzed by SDS–
AGE and autoradiography. In BS-C-1 cells infected with
R, the onset of viral late protein synthesis and shut off
f host protein synthesis occurred between 8 and 12 h
fter infection as revealed by the appearance of new
rominent bands (Fig. 5A). A similar pattern of viral pro-
ein synthesis occurred in BS-C-1 cells infected with
SPI-1 or DSPI-2 (Fig. 5A). In A549 cells, the onset of viral
ate protein synthesis and the profound shut-off of cell
rotein synthesis occurred between 12 and 18 h after
nfection with WR (Fig. 5B), consistent with the slower
roduction of infectious virus. A similar pattern also was
ound in A549 cells infected with DSPI-2 (Fig. 5B). Al-
hough viral late protein bands were detected in A549
ells infected with DSPI-1, their intensity was far less
han in cells infected with WR. The difference did not
esult from a delay in viral late protein synthesis because
he intensities of the bands were even lower at 36 and
8 h than at 24 h (data not shown).
The above results were confirmed by Western blotting
sing a broadly reactive antiserum that had been pre-
ared from a rabbit repeatedly immunized with purified lnfectious WR virions. The number and intensities of viral
roteins from BS-C-1 cells infected with WR, DSPI-1, or
SPI-2 were similar (Fig. 6A). By contrast, the intensities
f the bands were lower in A549 cells that were infected
ith DSPI-1 than with WR or DSPI-2 (Fig. 6B). These
esults were extended by using antibodies to specific
iral late proteins: an RNA-polymerase-associated factor
RAP94), a core component (4b), and a membrane pro-
ein (A17L). In each case, the intensities of the protein
ands were similar in BS-C-1 cells (Fig. 6C), whereas the
orresponding protein bands were specifically reduced
n A549 cells that were infected with DSPI-1 (Fig. 6D).
he A17L and 4b proteins were chosen because they
ndergo proteolytic cleavage at different stages of virus
aturation. Cleavage of the A17L protein precedes that
f the 4b protein (Betakova et al., 1999). Even though the
mount of A17L was less in A549 cells infected with
SPI-1 than WR or DSPI-2, the predominant species was
leaved (Fig. 6D). The predominant 4b species, however,
as the uncleaved form (Fig. 6D), suggesting a block in
irion maturation as well as an inhibition of viral late
rotein synthesis.
iral DNA replication in permissive
nd nonpermissive cells
Because viral late protein synthesis is dependent on
iral DNA replication, it was important to measure the
atter. Viral DNA was determined by applying lysates of
nfected cells to a membrane, which then was hybridized
ith a labeled viral DNA probe. DNA accumulation was
imilar in BS-C-1 and A549 cells whether they were
nfected with WR, DSPI-1, or DSPI-2 (Fig. 7). Thus the
iminished viral late protein synthesis was not correlated
ith a gross defect in viral DNA replication.
educed reporter gene expression in A549 cells
nfected with DSPI-1
As the form of the viral DNA that serves as the tem-
late for intermediate or late gene transcription is un-
nown, we could not rule out the possibility that the
eplicated DSPI-1 DNA was functionally less active than
R DNA. To bypass the genome replication requirement
or vaccinia virus intermediate and late gene expression,
ransfection assays were performed using plasmids con-
aining the Escherichia coli lacZ gene regulated by a viral
ntermediate or late promoter. Because intermediate
ranscription factors are synthesized before viral DNA
eplication, transfection assays were carried out in the
resence and absence of cytosine arabinoside, an inhib-
tor of DNA replication. Under both conditions, the level
f intermediate promoter regulated b-galactosidase was
ower in A549 cells infected with DSPI-1 than with WR
Fig. 8A). Because DNA replication is required for syn-
hesis of late transcription factors, transfection with the
ate promoter plasmid was only carried out in the ab-
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305VACCINIA VIRUS SERPIN-1 MUTANTence of cytosine arabinoside. Under these conditions,
xpression was also lower in A549 cells that were in-
ected with DSPI-1 than with WR (Fig. 8B).
teady-state levels of viral mRNAs in permissive
nd nonpermissive cells
To further analyze the expression defect, steady-state
evels of representative early (VGF), intermediate (G8R),
FIG. 5. Metabolic labeling of viral proteins under permissive and no
FU/cell of WR, DSPI-1, or DSPI-2. At the indicated hours after infection,
nalyzed by SDS polyacrylamide gel electrophoresis. Labeled proteins
heir masses in kDA are indicated on the left. The dots on the right innd late (11K) viral RNAs (Baldick and Moss, 1993) were wetermined in A549 cells infected with WR or DSPI-1.
qual amounts of total RNA were hybridized to a molar
xcess of radioactively labeled antisense riboprobes,
nd the products were digested with RNases and ana-
yzed by electrophoresis and autoradiography. VGF RNA
as detected between 2 and 8 h after infection of A549
ells with either WR or DSPI-1 (Fig. 9A). G8R RNA was
etected at 12 and 18 h after infection, but the amounts
ssive conditions. BS-C-1 (A) and A549 (B) cells were infected with 10
lls were labeled with [35S]methionine, and a portion of each lysate was
etected with a PhosphorImager. The positions of marker proteins and
prominent viral late proteins.npermi
the ce
were dere much less in A549 cells infected with DSPI-1 than
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306 SHISLER, ISAACS, AND MOSSR (Fig. 9B). The 11K RNA was measured between 12
nd 24 h after infection. Whereas it increased during this
eriod in cells infected with WR, with DSPI-1 only low
FIG. 6. Western blot analysis of viral proteins in BS-C-1 and A549 ce
ere lysed and the proteins subjected to SDS–PAGE. The proteins from
ncubated with rabbit polyclonal antibodies to: infectious vaccinia virus
ore protein, or the membrane protein A17L as indicated (C and D). A ho
f antigen–antibody complexes.
FIG. 7. Viral DNA replication under permissive and nonpermissive con
SPI-2 per cell. At the indicated times, cells were harvested and lysed a
he membranes were hybridized with 32P-labeled vaccinia virus DNA and radevels were detected at 12 and 18 h and was undetect-
ble at 24 h (Fig. 9C). Thus the defects in viral interme-
iate and late gene expression and virion formation in
ted with WR or DSPI-1. At the indicated hours after infection, the cells
-1 (A and C) and A549 (B and D) were transferred to a membrane and
A and B) or to the RNA polymerase-associated protein RAP94, the 4b
ish peroxidase-conjugated anti-rabbit antibody was used for detection
. (A) BS-C-1 or (B) A549 cells were infected with 10 PFU of WR, DSPI-1,
samples were applied to a nylon membrane using a slot blot manifold.lls infec
BS-C
(VV) (ditions
nd DNAioactivity was quantitated using a PhosphorImager.
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307VACCINIA VIRUS SERPIN-1 MUTANT549 cells infected with DSPI-1 could be attributed to the
ow levels of viral mRNA.
DISCUSSION
The present study arose from our interest in identifying
nd characterizing genes that encode inhibitors of
poptosis. We planned to remove endogenous apoptosis
nhibitor genes from vaccinia virus and then test the
bility of heterologous genes to functionally substitute
or them. A recent report, attributing the host range de-
ect resulting from deletion of the rabbitpox virus SPI-1
ene to apoptosis (Brooks et al., 1995), suggested to us
he possibility of using virus replication in a complemen-
ation assay for apoptosis inhibitors. A vaccinia virus
SPI-1 mutant was constructed and found to replicate
early 2 logs less efficiently than wild-type virus in hu-
an A549 cells, similar to what had been found for a
abbitpox virus DSPI-1 mutant (Ali et al., 1994). The host
ange defect was specific because the vaccinia virus
SPI-1 mutant replicated normally in BS-C-1 and other
ell lines and an independently isolated mutant had the
ame phenotype (J.L.S, unpublished data). By contrast,
accinia virus with a deletion of the nearby SPI-2 gene,
ad no replication defect in A549 cells. Although nuclear
nvagination and chromatin condensation were noted at
ate times in some DSPI-1-infected A549 cells, other
lassical morphological features of apoptosis were not
pparent. Also, none of the examined biochemical cor-
elates of apoptosis, e.g., DNA fragmentation or cleavage
f PARP, NuMA, or caspase-3 were associated with the
ost range defect. Indeed, the DSPI-1 mutant effectively
revented TNF-induced apoptosis of A549 cells,
hereas a DSPI-2 mutant did not. It remains possible
FIG. 8. Expression of intermediate and late genes from transfected pla
nd mock transfected (2) or transfected (1) with plasmids containing
r the late 11K promoter (B). After 24 h, b-galactosidase was measurehat SPI-1 interferes with other apoptotic pathways in m549 cells that were not examined. However, our original
lan to use the host restriction of DSPI-1 for screening
ovel apoptosis inhibitors was untenable.
The basis for the host range defects caused by dele-
ion of the SPI-1 genes of rabbitpox virus and vaccinia
irus is likely to be similar in view of the close relation-
hip of the two viruses and the common restriction for
549 cells. Although the SPI-1 host range defect of rab-
itpox virus appeared to be more strongly associated
ith apoptosis (Brooks et al., 1995) than described here
or vaccinia virus, subsequent studies failed to confirm
he association of DNA fragmentation with morphologi-
al changes and no other biochemical correlates of
poptosis were found in rabbitpox virus infected A549
ells (R. W. Moyer, personal communication). Moreover,
ven though apoptosis was demonstrated in pig kidney
LC-PK1 cells infected with a SPI-2 deletion mutant of
owpox virus, there was no reduction in the virus yield
Ray and Pickup, 1996). Furthermore the occurrence of
poptosis in Chinese hamster ovary cells infected with
accinia virus is not causally related to the host range
efect in those cells (Ink et al., 1995; Ramsey-Ewing and
oss, 1995). Thus a strong case has not been made for
poptosis causing any of the known host range defects
f orthopoxviruses. Where observed, apoptosis may be
nrelated to host restriction or actually a consequence
f it.
The above findings led us to undertake a more de-
ailed analysis of the host range restriction of the vac-
inia virus DSPI-1 mutant in A549 cells. Our results may
e summarized as follows: (1) viral early RNA synthesis
nd DNA replication were unaffected; (2) there were
ecreased amounts of viral intermediate and late
A549 cells were infected with WR (filled bars) or DSPI-1 (hatched bars)
Z open reading frame regulated by the intermediate G8R promoter (A)
, cytosine arabinoside.smids.
the lacRNAs; (3) viral late protein synthesis was severely
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308 SHISLER, ISAACS, AND MOSSeduced; and (4) few mature virus particles were de-
ected. The defect at the stage of intermediate and late
ene expression was corroborated by experiments in
hich reporter genes under control of intermediate and
ate promoters were transfected into cells infected with
SPI-1 or wild-type vaccinia virus. The effect on late
ene expression, as determined by RNA analysis and
ransfection, was more severe than that on intermediate
ene expression. This does not necessarily mean, how-
ver, that late transcription is intrinsically more sensitive
o the host range defect than intermediate transcription
ecause a cascade effect could result from the require-
ent for intermediate proteins as late transcription fac-
ors. Moreover because many late proteins are needed
o assemble virus particles, it is easy to see why virus
article formation was most severely inhibited of all pa-
ameters examined.
The K1L host range defect in rabbit kidney 13 cells
lso occurs at the level of intermediate gene expression.
n this case, the role of the K1L gene product has been
elated to an unidentified host factor required for tran-
FIG. 9. Detection of viral early, intermediate, and late mRNAs. Total
NA from A549 cells infected with WR or DSPI-1 for the indicated hours
as hybridized with 32P-labeled riboprobes specific for VGF early (A),
8R intermediate (B) or 11K late (C) mRNAs. The samples were di-
ested with RNase, analyzed by gel electrophoresis, and autoradio-
raphed.cription of intermediate genes (Rosales et al., 1994; Tutter et al., 1994). A host factor is also necessary for
ranscription of late genes (Gunasinghe et al., 1998; Zhu
t al., 1998). Our working hypothesis is that expression of
ome viral genes (e.g., K1L, CHO hr, SPI-1) modulates
he activities of host proteins that serve as viral transcrip-
ion factors. The activities of these host factors may vary
n different cell lines and under different physiological
onditions, as suggested by our finding that the host
ange defect of vaccinia virus DSPI-1 in primary keratin-
cytes can be overcome by inducing cell differentiation.
t will be important to determine whether the role of SPI-1
n allowing orthopoxvirus replication in A549 cells is
ependent on proteinase inhibition and if so on which
roteinase. To address this question, we mutated SPI-1
y simply exchanging the amino acids at the P1 and P19
ites predicted to be critical for serpin activity. Although
he recombinant vaccinia virus exhibited a host range
efect in A549 cells, further analysis indicated that the
utation destabilized SPI-1, thereby preventing us from
rawing any specific conclusions regarding the mecha-
ism of action of SPI-1 (J. L. Shisler and B. Moss, unpub-
ished results).
METHODS
ells and virus
Primary human epidermal keratinocytes were isolated
rom neonatal foreskins and cultured in defined keratin-
cyte serum-free medium (Life Technologies). A549 and
S-C-1 cells were obtained from American Type Culture
ollection and grown in DMEM (Quality Biologicals) sup-
lemented with 10% fetal calf serum (FCS) and glu-
amine. The medium was supplemented with mycophe-
olic acid (25 mg/ml), xanthine (250 mg/ml), and hypo-
anthine (15 mg/ml) as described (Falkner and Moss,
988) for gpt selection.
Deletion mutants were prepared by homologous re-
ombination essentially as described (Earl et al., 1998b)
sing plasmids with a gpt cassette inserted between the
peI and SplI sites of SPI-1 or the EcoRV sites of SPI-2 to
roduce deletions of 585 and 300 bp, respectively .
Immunostaining of virus plaques and virus yield deter-
inations were carried out essentially as described (Earl
t al., 1998a).
NF cytolysis assay
Monolayer of A549 cells in six-well plates were in-
ected with virus at of 10 PFU per cell in medium con-
aining 2.5% FCS. After a 60-min absorption, cells were
insed once and then incubated with medium containing
0% FCS for 12 h. Uninfected and infected cells were
dded to standard 96-well microtiter plates (10,000 cells/
ell) that contained either medium alone (to determine
pontaneous release) or increasing concentrations of
NF (Boehringer Mannheim). After 18 h, lysis solution
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309VACCINIA VIRUS SERPIN-1 MUTANTas added to one set of wells to determine the maximum
elease of lactate dehydrogenase (LDH) using the Cyto-
ox96 kit from Promega Corp. Supernatants were har-
ested and also tested for LDH. The percent specific
ytolysis was determined by the following formula: [(ex-
erimental release 2 spontaneous release)/(maximum
elease 2 spontaneous release)] x 100. The spontane-
us release for all experiments was no more than 40% of
he maximum. All determinations were done in triplicate
nd presented as the mean value.
estern blot analysis of cell proteins
A549 cells (106) were infected with vaccinia virus at a
ultiplicity of 10 PFU per cell or treated with 50 mg/ml of
HX (Sigma), 100 ng/ml of TNF (Boerhinger Mannheim)
r both CHX and TNF. At 24 h after infection, cells were
ollected by centrifugation and lysed in 35 mM glucose,
6 mM Tris–HCl (pH 8), 7 mM EDTA, 0.6 mM PMSF, 17
M Tris–HCl (pH 6.8), 2 M urea, 2% 2-mercaptoethanol,
% SDS, 0.003% bromphenol blue. DNA was sheared
sing a 21-gauge needle, and a portion of each lysate
as boiled for 5 min and loaded on a SDS 4–20% poly-
crylamide gel. Proteins were transferred electrophoreti-
ally to PVDF membranes (Millipore Corporation) and
locked with TTBS [1M Tris–HCl (pH 7.5), 5M NaCl,
ween 20] containing 2.5% non-fat dry milk in solution.
lots were incubated for 1 h with one of the following
rimary antibodies in TTBS containing 0.5% milk: poly-
lonal rabbit anti-PARP (Boehringer Mannheim) diluted
:2000; polyclonal rabbit anti-caspase-3 (Pharmingen)
iluted 1:1000; mouse monoclonal anti-NuMA (Calbio-
hem) diluted 1:40. After incubation with primary anti-
ody, blots were rinsed three times with TTBS containing
.5% milk and then incubated with a 1:10000 dilution of
he appropriate HRPO-conjugated anti-rabbit or anti-
ouse antibodies (Amersham) for 45 min. Blots were
ashed again in TTBS 1 0.5% milk, incubated with the
ierce SuperSignal Chemiluminescent Kit, and exposed
o Kodak film.
UNEL assay
A549 cells were seeded at 104 cells/chamber on an
ight-well chamber slide. Cells were infected at a m.o.i.
f 10 PFU/cell in medium with 2.5% FCS for 60 min. After
bsorption, the infected cell monolayer was rinsed once
ith phosphate-buffered saline and incubated with me-
ium with 10% FCS for 12 h. Monolayers were fixed and
tained using the AP In Situ Cell Death Detection Kit
Boerhinger Mannheim) and photographed under an in-
erted light microscope.
reparation of samples for electron microscopy
A549 cells (106) were seeded in 60-mm dishes and
nfected with 10 PFU per cell of vaccinia virus. At 24 h
fter infection, the cells were fixed, dehydrated, embed- ced, sectioned, collected on grids, and stained with lead
itrate as previously described (Wolffe et al., 1993).
estern blot analysis of viral proteins
Infected cells (106) were collected and incubated in 0.5
l of hypotonic lysis buffer (0.06 M Tris–HCl (pH 6.8), 3%
DS, 10% glycerol, 5% fresh 2-mercaptoethanol, 0.002%
romphenol blue). The lysate was cleared by centrifuga-
ion at 12,000 g and a portion of each sample was mixed
ith SDS/2-mercaptoethanol sample buffer and boiled
or 5 min. After polyacrylamide gel electrophoresis, the
roteins were transferred electrophoretically to PVDF
embranes (Millipore) and blocked with TTBS contain-
ng 2.5% non-fat dry milk. Blots were incubated for 1 h
ith a 1:2000 dilution of a rabbit polyclonal anti-vaccinia
irus antibody (raised against purified infectious virus) in
TBS containing 0.5% milk. Rabbit antibody to RAP94
Ahn et al., 1994), the N terminus of the A17L protein
Betakova et al., 1999), and the 4b core protein were used
t a 1:1000 dilution. After incubation with each primary
ntibody, the blots were incubated with HRPO-conju-
ated secondary antibody as described above.
etabolic labeling of viral proteins
Approximately 106 cells were seeded into six-well
lates and infected with wild-type or mutant viruses at a
.o.i. of 10 PFU/cell. At 15 min before each labeling
eriod, the cells were washed twice and incubated with
rewarmed methionine-free medium. The cells then
ere incubated with 100 mCi of [35S]methionine in 0.5 ml
ethionine-free medium for 30 min. The labeling me-
ium was removed and the cells were washed twice with
BS and then incubated at 37°C for 5 min with 0.5 ml of
ypotonic lysis buffer [20 mM Tris–HCl (pH 8.0), 10 mM
aCl, 0.5% Nonidet-P40 (NP-40)]. The lysate was col-
ected and centrifuged for 2 min at 12,000 g to pellet
uclei. A portion of each sample was mixed with SDS/
-mercaptoethanol sample buffer, boiled for 5 min and
esolved by electrophoresis in a SDS 4–20% polyacryl-
mide gel. Radioactive proteins were visualized using a
hosphorImager.
nalysis of viral DNA
Cells in 12-well plates were infected with 10 PFU/cell
f vaccinia virus. At various times after infection, the cells
ere collected by centrifugation, suspended in 0.2 ml of
BS, and lysed by three freeze–thaw cycles and sonica-
ion. The lysates (0.1 ml) containing DNA were applied to
nylon transfer membrane (Amersham) using a slot blot
pparatus. The membrane was treated sequentially with
.5 M NaOH, 1 M Tris–HCl (pH 7.5) and 2[mult] SSC (0.3
NaCl, 0.03 M Na citrate) and UV cross-linked. The
embrane was incubated with a 32P-labeled cloned vac-inia virus DNA probe in Rapi-Hybe Solution (Amer-
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310 SHISLER, ISAACS, AND MOSSham). Radioactivity was quantitated using the Phospho-
mager.
nalysis of viral RNA
Monolayers of A549 cells in six-well tissue culture
rays (106 cells/well) were infected with 10 PFU/cell of
accinia virus. At various times, total cellular RNA was
xtracted using the RNAqueous kit (Ambion) and 1 mg
as hybridized to a molar excess of 32P-labeled ribo-
robes prepared as previously described (Baldick and
oss, 1993). RNase protected probe fragments were
nalyzed by electrophoresis on a 5% polyacrylamide–8
urea gel and visualized by autoradiography as de-
cribed (Baldick and Moss, 1993).
ACKNOWLEDGMENTS
We thank Maureen Ferran and Alison McBride for primary human
eratinocytes and advice regarding their culture, Norman Cooper for
upplying BS-C-1 and A549 cells, Elizabeth Wolffe and Andrea Weis-
erg for electron microscopy, and Richard Moyer for communicating
npublished information.
REFERENCES
hn, B.-Y., Gershon, P. D., and Moss, B. (1994). RNA-polymerase asso-
ciated protein RAP94 confers promoter specificity for initiating tran-
scription of vaccinia virus early stage genes. J. Biol. Chem. 269,
7552–7557.
li, A. N., Turner, P. C., Brooks, M. A., and Moyer, R. W. (1994). The SPI-1
gene of rabbitpox virus determines host range and is required for
hemorrhagic pock formation. Virology 202, 305–314.
ntoine, G., Scheiflinger, F., Dorner, F., and Falkner, F. G. (1998). The
complete genomic sequence of the modified vaccinia Ankara strain:
Comparison with other orthopoxviruses. Virology 244, 365–396.
aldick, C. J., Jr., and Moss, B. (1993). Characterization and temporal
regulation of mRNAs encoded by vaccinia virus intermediate stage
genes. J. Virol. 67, 3515–3527.
eattie, E., Kauffman, E. B., Martinez, H., Perkus, M. E., Jacobs, B. L.,
Paoletti, E., and Tartaglia, J. (1996). Host-range restriction of vaccinia
virus E3L-specific deletion mutants. Virus Genes 12, 89–94.
etakova, T., Wolffe, E. J., and Moss, B. (1999). Regulation of vaccinia
virus morphogenesis: Phosphorylation of the A14L and A17L mem-
brane proteins and C-terminal truncation of the A17L protein are
dependent on the F10L protein kinase. J. Virol. 73, 3534–3543.
ird, P. I. (1998). Serpins and regulation of cell death. Results Probl. Cell
Differ. 24, 63–89.
oursnell, M. E. G., Foulds, I. J., Campbell, J. I., and Binns, M. M. (1988).
Non-essential genes in the vaccinia virus HindIII K fragment: A gene
related to serine protease inhibitors and a gene related to the 37K
vaccinia virus major envelope antigen. J. Gen. Virol. 69, 2995–3003.
owden, R. J., Simas, J. P., Davis, A. J., and Efstathiou, S. (1997). Murine
gammaherpesvirus 68 encodes tRNA-like sequences which are ex-
pressed during latency. J. Gen Virol. 78, 1675–1687.
rooks, M. A., Ali, A. N., Turner, P. C., and Moyer, R. W. (1995). A
rabbitpox virus serpin gene controls host range by inhibiting
apoptosis in restrictive cells. J. Virol. 69, 7688–7698.
arroll, M., and Moss, B. (1997). Host range and cytopathogenicity of
the highly attenuated MVA strain of vaccinia virus: Propagation and
generation of recombinant viruses in a nonhuman mammalian cell
line. Virology 238, 198–211.
asciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thorn-
berry, N. A., Miller, D. K., and Rosen, A. (1996). Apopain/CPP32cleaves proteins that are essential for cellular repair: A fundamental
principle of apoptotic death. J. Exp. Med. 183, 1957–1964.
hang, H.-W., Uribe, L. H., and Jacobs, B. L. (1995). Rescue of vaccinia
virus lacking the E3L gene by mutants of E3L. J. Virol. 69, 6605–6608.
hang, H. W., Watson, J. C., and Jacobs, B. L. (1992). The E3L gene of
vaccinia virus encodes an inhibitor of the interferon-induced, double-
stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA
89, 4825–4829.
obbelstein, M., and Shenk, T. (1996). Protection against apoptosis by
the vaccinia virus SPI-2 (B13R) gene product. J. Virol. 70, 6479–6485.
rexler, I., Heller, K., Wahren, B., Erfle, V., and Sutter, G. (1998). Highly
attenuated modified vaccinia virus Ankara replicates in baby ham-
ster kidney cells, a potential host for virus propagation, but not in
various human transformed and primary cells. J. Gen. Virol. 79,
347–352.
arl, P. L., Cooper, N., Wyatt, S., Moss, B., and Carroll, M. W. (1998a).
Preparation of cell cultures and vaccinia virus stocks. In “Current
Protocols in Molecular Biology” (F. M. Ausubel, R. Brent, R. E. King-
ston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, Eds.), Vol.
2, pp. 16.16.1–16.16.3. John Wiley and Sons, New York.
arl, P. L., Moss, B., Wyatt, L. S., and Carroll, M. W. (1998b). Generation
of recombinant vaccinia viruses. In “Current Protocols in Molecular
Biology” (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G.
Seidman, J. A. Smith, and K. Struhl, Eds.), Vol. 2, pp. 16.17.1–16.17.19.
Greene Publishing Associates and Wiley Interscience, New York.
alkner, F. G., and Moss, B. (1988). Escherichia coli gpt gene provides
dominant selection for vaccinia virus open reading frame expression
vectors. J. Virol. 62, 1849–1854.
illard, S., Spehner, D., and Drillien, R. (1985). Mapping of a vaccinia
virus host range sequence by insertion into the viral thymidine
kinase gene. J. Virol. 53, 316–318.
unasinghe, S. K., Hubbs, A. E., and Wright, C. F. (1998). A vaccinia virus
late transcription factor with biochemical and molecular identity to a
human cellular protein. J. Biol. Chem. 273, 27524–27530.
nk, B. S., Gilbert, C. S., and Evan, G. I. (1995). Delay of vaccinia
virus-induced apoptosis in nonpermisive hamster ovary cells by the
cowpox virus CHOhr and adenovirus E1B 19K genes. J. Virol. 69,
661–668.
eane, R. W., Srinivasan, A., Foster, L. M., Testa, M. P., Ord, T., Nonner,
D., Wang, H. G., Reed, J. C., Bredesen, D. E., and Kayalar, C. (1997).
Activation of CPP32 during apoptosis of neurons and astrocytes.
J. Neurosci. Res. 48, 168–180.
ettle, S., Alcami, A., Khanna, A., Ehret, R., Jassoy, C., and Smith, G. L.
(1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1-b
converting enzyme and protects virus-infected cells from TNF- and
Fas-mediated apoptosis, but does not prevent IL-1b-induced fever.
J. Gen. Virol. 78, 677–685.
ettle, S., Blake, N. W., Law, K. M., and Smith, G. L. (1995). Vaccinia virus
serpins B13R (SPI-2) and B22R (SPI-1) encode Mr 38.5 and 40K
intracellular polypeptides that do not affect virus virulence in a
murine intranasal model. Virology 206, 136–147.
otwal, G. J., and Moss, B. (1989). Vaccinia virus encodes two proteins
that are structurally related to members of the plasma serine pro-
tease inhibitor superfamily. J. Virol. 63, 600–606.
aw, K. M., and Smith, G. L. (1992). A vaccinia serine protease inhibitor
which prevents virus-induced cell fusion. J. Gen. Virol. 73, 549–557.
acen, J. L., Garner, R., Musy, P. Y., Brooks, M. A., Turner, P. C., Moyer,
R. W., McFadden, G., and Bleackley, R. C. (1996). Differential inhibition
of the Fas- and granule-mediated cytolysis pathways by the or-
thopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein.
Proc. Natl. Acad. Sci. USA 93, 9108–9113.
acen, J. L., Upton, C., Nation, N., and McFadden, G. (1993). SERP1, a
serine protease inhibitor encoded by myxoma virus, is a secreted
glycoprotein that interferes with inflammation. Virology 195, 348–363.
essud-Petit, F., Gelfi, J., Delverdier, M., Amardeilh, M. F., Py, R., Sutter,
G., and Bertagnoli, S. (1998). Serp2, an inhibitor of the interleukin-1
MM
N
P
Q
R
R
R
R
R
R
S
S
S
S
S
T
T
T
W
W
W
W
Z
Z
311VACCINIA VIRUS SERPIN-1 MUTANTbeta-converting enzyme, is critical in the pathobiology of myxoma
virus. J. Virol. 72, 7830–7839.
eyer, H., Sutter, G., and Mayr, A. (1991). Mapping of deletions in the
genome of the highly attenuated vaccinia virus MVA and their influ-
ence on virulence. J. Gen. Virol. 72, 1031–1038.
oss, B. (1996). Poxviridae: The viruses and their replication. In “Fields
Virology” (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed.,
Vol. 2, pp. 2637–2671. Lippincott-Raven Publishers, Philadelphia.
ash, P., Whitty, A., Handwerker, J., Macen, J., and McFadden, G. (1998).
Inhibitory specificity of the anti-inflammatory myxoma virus serpin,
SERP-1. J. Biol. Chem. 273, 20982–20991.
etit, F., Bertagnoli, Gelfi, J., Fasy, F., Boucraut-Baralon, C., and Milon, A.
(1996). Characterization of a myxoma virus-encoded serpin-like pro-
tein with activity against interleukin-1b-converting enzymes. J.Virol.
70, 5860–5866.
uan, L. T., Caputo, A., Bleackley, R. C., Pickup, D. J., and Salvesen,
G. S. (1995). Granzyme B is inhibited by the cowpox virus serpin
cytokine response modifier A. J. Biol. Chem 270, 10377–10379.
amsey-Ewing, A., and Moss, B. (1995). Restriction of vaccinia virus
replication in CHO cells occurs at the stage of viral intermediate
protein synthesis. Virology 206, 984–993.
amsey-Ewing, A. L., and Moss, B. (1996). Complementation of a
vaccinia virus host range K1L gene deletion by the non-homologous
CP77 gene. Virology 222, 75–86.
amsey-Ewing, A., and Moss, B. (1998). Apoptosis induced by a post-
binding step of vaccinia virus entry into Chinese hamster ovary cells.
Virology 242, 138–149.
ay, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R.,
Salvesen, G. S., and Pickup, D. J. (1992). Viral inhibition of inflamma-
tion—cowpox virus encodes an inhibitor of the interleukin-1b con-
verting enzyme. Cell 69, 597–604.
ay, C. A., and Pickup, D. J. (1996). The mode of death of pig kidney cells
infected with cowpox virus is governed by the expression of the crmA
gene. Virology 217, 384–391.
osales, R., Sutter, G., and Moss, B. (1994). A cellular factor is required
for transcription of vaccinia viral intermediate stage genes. Proc.
Natl. Acad. Sci. USA 91, 3794–3798.
imas, J. P., Bowden, R. J., Paige, V., and Efstathiou, S. (1998). Four
tRNA-like sequences and a serpin homologue encoded by murine
gammaherpesvirus 68 are dispensable for lytic replication in vitro
and latency in vivo. J. Gen. Virol. 79, 149–153.mith, G. L., Howard, S. T., and Chan, T. S. (1989). Vaccinia virus
encodes a family of genes with homology to serine protease inhib-
itors. J. Gen. Virol. 70, 2333–2343.
pehner, D., Gillard, S., Drillien, R., and Kirn, A. (1988). A cowpox virus
gene required for multiplication in Chinese hamster ovary cells.
J. Virol. 62, 1297–1304.
utter, G., and Moss, B. (1992). Nonreplicating vaccinia vector effi-
ciently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89,
10847–10851.
utter, G., Ramsey-Ewing, A., Rosales, R., and Moss, B. (1994). Stable
expression of the vaccinia virus K1L gene in rabbit cells comple-
ments the host range defect of a vaccinia virus mutant. J. Virol. 68,
4109–4116.
ewari, M., and Dixit, V. M. (1995). Fas- and tumor necrosis factor-
induced apoptosis is inhibited by the poxvirus crmA gene product. J.
Biol. Chem 270, 3255–3260.
urner, P. C., and Moyer, R. W. (1992). An orthopoxvirus serpin-like gene
controls the ability of infected cells to fuse. J. Virol. 66, 2076–2085.
urner, P. C., and Moyer, R. W. (1995). Orthopoxvirus fusion inhibitor
glycoprotein SPI-3 (open reading frame K2L) contains motifs char-
acteristic of serine protease inhibitors that are not required for
control of cell fusion. J. Virol. 69, 5978–5987.
eaver, V. M., Carson, C. E., Walker, P. R., Chaly, N., Lach, B., Raymond,
Y., Brown, D. L., and Sikorska, M. (1996). Degradation of nuclear
matrix and DNA cleavage in apoptotic thymocytes. J. Cell Sci. 109,
45–56.
hisstock, J., Skinner, R., and Lesk, A. M. (1998). An atlas of serpin
conformations. Trends Biochem. Sci. 23, 63–67.
olffe, E. J., Isaacs, S. N., and Moss, B. (1993). Deletion of the vaccinia
virus B5R gene encoding a 42-kilodalton membrane glycoprotein
inhibits extracellular virus envelope formation and dissemination.
J. Virol. 67, 4732–4741.
yatt, L. S., Carroll, M. W., Czerny, C.-P., Merchlinsky, M., Sisler, J. R.,
and Moss, B. (1998). Marker rescue of the host range restricted
defects of modfied vaccinia virus Ankara. Virology 251, 334–342.
hou, J., Sun, X. Y., Fernando, G. J. P., and Frazer, I. H. (1992). The
vaccinia virus K2L gene encodes a serine protease inhibitor which
inhibits cell–cell fusion. Virology 189, 678–686.
hu, M., Moore, T., and Broyles, S. S. (1998). A cellular protein binds
vaccinia virus late promoters and activates transcription in vitro.
J. Virol. 72, 3893–3899.
